Revenue + Forward P/E
Encompass Health Corporation (EHC) quarterly revenue and forward P/EForward P/E: 19.9x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$12.31B
Enterprise value
$13.64B
P/E ratio (TTM)
18.27x
P/S ratio (TTM)
1.82x
P/B ratio
4.37x
EV/Sales
2.25x
EV/EBITDA
9.33x
Dividend yield
0.68%
Income statement (TTM)
Revenue (TTM)
$5.94B
Gross profit (TTM)
$5.68B
Operating income (TTM)
$1.05B
EBITDA (TTM)
$1.40B
Net income (TTM)
$566.20M
Free cash flow (TTM)
$439.20M
Margins & returns
Gross margin
58.82%
Operating margin
17.93%
Profit margin
10.04%
Return on equity
25.35%
Return on assets
8.33%
Per-share metrics
EPS (TTM)
$6.14
Dividend yield
0.68%
Beta
0.60
Capital structure
Cash & equivalents
$102.90M
Total debt
$2.71B
Net debt
$2.61B
Shares outstanding
99.20M
Financial health
Current ratio
1.08
Debt / equity
1.11
Debt / assets
0.38
Interest coverage
8.55
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.14T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $629.80B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.20B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.07B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.41B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $12.31B | 18.27x | 1.82x | 9.33x | 0.68% |